Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension

This study has been completed.
Sponsor:
Collaborator:
Mallinckrodt
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Heart, Lung, and Blood Institute (NHLBI) )
ClinicalTrials.gov Identifier:
NCT00023296
First received: September 3, 2001
Last updated: November 10, 2015
Last verified: November 2015